Category: Bio
-
Edwards Lifesciences buys Israeli co Innovalve Bio Medical
•
Edwards Lifesciences (NYSE: EW) today announced that it has exercised its option to acquire an early-stage Israeli transvascular coronary angioplasty company Inovalife Biomedical IndustriesNo financial details were disclosed, but the acquisition is estimated to be worth hundreds of millions of dollars. Innovalve was founded at the Sheba Medical Center in…
-
Gossamer Bio a new outperform at Oppenheimer on seralutinib for PAH
•
George Clerk Oppenheimer launched Gossamer Bio into an outperformance expressing optimism about seralutinib, an inhaled tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The company has a price target of $9 (~984% upside based on June 24 close). Analyst Andreas Argyrides said that the safety of the…
-
Gritstone bio details progress in cancer vaccine trials By Investing.com
•
Gritstone bio (GRTS) has unveiled promising preliminary data from its GRANITE personalized cancer vaccine program during its First Quarter 2024 Earnings Call. The clinical updates showed a positive trend in progression-free survival (PFS) for colorectal cancer patients, with particularly encouraging results in high-risk individuals. The company’s financial position was also…
-
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention By Investing.com
•
new Taipei city, May 11, 2024 /PRNewswire/ — Calliway Biopharmaceuticals (Calliway) is pleased to announce its partnership to share the latest clinical developments in the upcoming 2024 year Vital International Convention on Wednesday, June 5in 11:45 AM PT. The presentation will take place at Theater show company 2 in San…